These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 832522)

  • 1. Fosfomycin in the treatment of bacterial infections: summary of clinical trials in Japan.
    Fujii R
    Chemotherapy; 1977; 23 Suppl 1():234-46. PubMed ID: 832522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fosfomycin in the treatment of some infectious diseases].
    Aceti A; Vullo V; Ferone U; Delia S
    Clin Ter; 1979 Jan; 88(1):61-6. PubMed ID: 436378
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of fosfomycin in the treatment of bacterial infections.
    Hutzler R; Fernandes V; Muñoz D; Rozentraub A
    Chemotherapy; 1977; 23 Suppl 1():358-64. PubMed ID: 832537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of respiratory infections with fosfomycin.
    Menéndez A; Tutor A; Sousa AS
    Chemotherapy; 1977; 23 Suppl 1():348-57. PubMed ID: 832536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriological evaluation of fosfomycin in clinical studies.
    Rodríguez A; Gallego A; Olay T; Mata JM
    Chemotherapy; 1977; 23 Suppl 1():247-58. PubMed ID: 832523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.
    Patel SS; Balfour JA; Bryson HM
    Drugs; 1997 Apr; 53(4):637-56. PubMed ID: 9098664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives for reassessing fosfomycin: applicability in current clinical practice.
    Candel FJ; Matesanz David M; Barberán J
    Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):1-7. PubMed ID: 31131586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis.
    Seroy JT; Grim SA; Reid GE; Wellington T; Clark NM
    J Antimicrob Chemother; 2016 Sep; 71(9):2563-8. PubMed ID: 27246234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical suppurating infections and surgical abdominal infections treated with fosfomycin.
    Gallardo A; Sáez JM; Enriquez G; Cobacho AR; Torronteras R; Recordan C; Del Moral A; Arroyo A; Curiel AG
    Chemotherapy; 1977; 23 Suppl 1():392-8. PubMed ID: 832540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosfomycin. Controlled clinical studies.
    Rodriguez A; Olay T; Vicente MV; Oliver LE
    G Ital Chemioter; 1977; 23(2):127-32. PubMed ID: 342325
    [No Abstract]   [Full Text] [Related]  

  • 11. The revival of fosfomycin.
    Michalopoulos AS; Livaditis IG; Gougoutas V
    Int J Infect Dis; 2011 Nov; 15(11):e732-9. PubMed ID: 21945848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosfomycin in infantile acute gastroenteritis.
    Brines J; Escribano A; Bori JV; Colomer J
    Chemotherapy; 1977; 23 Suppl 1():304-9. PubMed ID: 832529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosfomycin in the treatment of gynecological infections.
    Gobernado M; Pérez de León A; Santos M; Mateo C; Ferreres L
    Chemotherapy; 1977; 23 Suppl 1():287-92. PubMed ID: 832527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of fosfomycin].
    Lan CK
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Mar; 45(3):181-5. PubMed ID: 2168262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fosfomycin for the treatment of resistant gram-negative bacterial infections. Insights from the Society of Infectious Diseases Pharmacists.
    Reffert JL; Smith WJ
    Pharmacotherapy; 2014 Aug; 34(8):845-57. PubMed ID: 24782335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous fosfomycin for the treatment of hospitalized patients with serious infections.
    Shorr AF; Pogue JM; Mohr JF
    Expert Rev Anti Infect Ther; 2017 Oct; 15(10):935-945. PubMed ID: 28901793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZTI-01 (fosfomycin for injection) in the treatment of hospitalized patients with complicated urinary tract infections.
    Burgos RM; Rodvold KA
    Future Microbiol; 2019 Apr; 14():461-475. PubMed ID: 30854892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral and intravenous fosfomycin in complicated urinary tract infections.
    López-Montesinos I; Horcajada JP
    Rev Esp Quimioter; 2019 May; 32 Suppl 1(Suppl 1):37-44. PubMed ID: 31131591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fosfomycin: past, present and future].
    Baylan O
    Mikrobiyol Bul; 2010 Apr; 44(2):311-21. PubMed ID: 20549968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical experience with fosfomycin sodium for infectious diseases in obstetrics and gynecology].
    Yamazaki T; Ogura T; Kawamura M
    Jpn J Antibiot; 1983 Aug; 36(8):2115-9. PubMed ID: 6655829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.